A-867744 25mg 25mg | Purity Not Available
Adooq Bioscience
A-867744 is a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.
More Information Supplier PageA-867744 is a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.
More Information Supplier PageA-867744 is a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.
More Information Supplier PageApremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
More Information Supplier PageApremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
More Information Supplier PageApremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
More Information Supplier PageApremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
More Information Supplier PageApremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
More Information Supplier PageA-867744 is a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier PageAmbrisentan functions as an endothelin receptor antagonist, and is selective for the type A endothelin receptor (ETA).
More Information Supplier Page